Trading / Browse Companies / Seer Stock

Seer Stock

seer.bioHealthcareFounded: 2017Funding to Date: $108.5MM

Seer is a provider of innovative solutions that act as a gateway to the proteome.

Buy or sell Seer stockLearn more about a potential Seer IPO
Register for Details

For more details on financing and valuation for Seer, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Seer.

Register Today

Team

Management Team

Robert Langer Ph.D
Co-Founder, Board Member & Chairman of Scientific Advisory Board
Omid Farokhzad MD
Co-Founder, Chief Executive Officer & Board Member
Philip Ma Ph.D
Co-Founder, President & Chief Business Officer

Board Members

Mark McClellan Ph.D
Terrance McGuire
David Hallal
Omid Farokhzad MD
David Singer
Maverick Ventures
Robert Langer Ph.D

Other companies like Seer in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B

News

Genomeweb 02/28/2022
Seer Q4 Revenues Grow Nearly Tenfold
The company posted revenues of $3.1 million, up from $336,000 in the year-ago period and beating the consensus Wall Street estimate of $2.2 million.
Genomeweb 11/12/2021
Seer Collaborators Release Data Indicating Proteograph Platform's Utility for Proteomics Research
The company and its early-access users have recently published data from several studies indicating that its platform can boost plasma proteome coverage.
Genomeweb 08/12/2021
Seer Q2 Revenues Skyrocket; Firm Inks Chinese Distribution Deal
The company posted revenues of $1.3 million, up from $71,000 in the year-ago period and above the consensus Wall Street estimate of $790,000.

Trending Companies

Frequently Asked Questions